Northwest Biotherapeutics (NWBO) EBT Margin (QoQ) (2013 - 2026)
Northwest Biotherapeutics (NWBO) EBT Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Northwest Biotherapeutics | 253,653.43 | -1.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28,167.00 |
| Dec 31, 2025 | 607,080.00 |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | -1.38 Mn |
| Mar 31, 2025 | 631,194.00 |
| Dec 31, 2024 | -662,684.00 |
| Sep 30, 2024 | -97,092.00 |
| Jun 30, 2024 | 232,052.00 |
| Mar 31, 2024 | -338,424.00 |
| Dec 31, 2023 | 112,996.00 |
| Sep 30, 2023 | 357,860.00 |
| Jun 30, 2023 | -581,260.00 |
| Mar 31, 2023 | 166,740.00 |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | -5.85 Mn |
| Jun 30, 2022 | -120,264.00 |
| Sep 30, 2021 | -15,299.00 |
| Jun 30, 2021 | 561,728.00 |
| Mar 31, 2021 | -473,706.00 |
| Dec 31, 2020 | 2.07 Mn |